Back to Search Start Over

ClorNovir by Dr. Ferrer BioPharma Named Finalist at CPHI Pharma Awards 2024 for Breakthrough COVID-19 and Post-COVID Care

Source :
Business Wire. October 9, 2024
Publication Year :
2024

Abstract

MILAN -- Dr. Ferrer BioPharma (DFB) is excited to announce that ClorNovir, its cutting-edge nasal spray for early COVID-19 treatment, has been selected as a finalist in the Finished Formulation [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Business Wire
Publication Type :
News
Accession number :
edsgcl.811662513